| # | Title | Journal | Year | Citations |
|---|
| 1 | Treatment outcomes for 618 women with gestational trophoblastic tumours following a molar pregnancy at the Charing Cross Hospital, 2000–2009 | British Journal of Cancer | 2012 | 114 |
| 2 | Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001) | British Journal of Cancer | 2013 | 111 |
| 3 | Advanced Intrahepatic Cholangiocarcinoma: Post Hoc Analysis of the ABC-01, -02, and -03 Clinical Trials | Journal of the National Cancer Institute | 2020 | 90 |
| 4 | The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer | British Journal of Cancer | 2009 | 87 |
| 5 | Breast cancer: Current and future endocrine therapies | Molecular and Cellular Endocrinology | 2014 | 81 |
| 6 | Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment | British Journal of Cancer | 2009 | 78 |
| 7 | The Efficacy of Axillary Ultrasound in the Detection of Nodal Metastasis in Breast Cancer | American Journal of Roentgenology | 2013 | 76 |
| 8 | A 2009 Update on the Treatment of Patients with Hormone Receptor—Positive Breast Cancer | Clinical Breast Cancer | 2009 | 71 |
| 9 | Uterine artery pulsatility index: a predictor of methotrexate resistance in gestational trophoblastic neoplasia | British Journal of Cancer | 2012 | 44 |
| 10 | The demographics of molar pregnancies in England and Wales from 2000-2009 | Journal of reproductive medicine, The | 2010 | 43 |
| 11 | Successful treatment of metastatic hepatic epithelioid hemangioendothelioma with thalidomide: a case report | Journal of Medical Case Reports | 2010 | 42 |
| 12 | Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis | European Journal of Cancer | 2009 | 37 |
| 13 | ‘Being there’ for women with metastatic breast cancer: a pan-European patient survey | British Journal of Cancer | 2013 | 31 |
| 14 | Placental site trophoblastic tumours and the concept of fertility preservation | BJOG: an International Journal of Obstetrics and Gynaecology | 2012 | 28 |
| 15 | IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer | Breast Cancer Research and Treatment | 2017 | 24 |
| 16 | Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer | British Journal of Cancer | 2013 | 20 |
| 17 | Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Relapsing Post-Adjuvant Trastuzumab: Pattern of Recurrence, Treatment and Outcome | Clinical Breast Cancer | 2011 | 18 |
| 18 | Primary Esophageal Carcinoma in the Era of Highly Active Antiretroviral Therapy | Archives of Internal Medicine | 2010 | 17 |
| 19 | Activity of eribulin mesylate in heavily pretreated breast cancer granted accessvia the Cancer Drugs Fund | Future Oncology | 2014 | 16 |
| 20 | A phase II study of carboplatin AUC-10 guided by positron emission tomography–defined metabolic response in metastatic seminoma | European Journal of Cancer | 2019 | 14 |
| 21 | Multicenter Experience of Nonpegylated Liposomal Doxorubicin Use in the Management of Metastatic Breast Cancer | Clinical Breast Cancer | 2014 | 13 |
| 22 | Embolization of uterine arteriovenous malformations in patients with gestational trophoblastic tumors: a review of patients at Charing Cross Hospital, 2000-2009 | Journal of reproductive medicine, The | 2012 | 13 |
| 23 | The preferences and experiences of different bisphosphonate treatments in women with breast cancer | Psycho-Oncology | 2011 | 9 |
| 24 | Partial molar pregnancy after intracytoplasmic sperm injection occurring as a result of diploid sperm usage | Journal of Assisted Reproduction and Genetics | 2013 | 9 |
| 25 | Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy | ESMO Open | 2021 | 9 |
| 26 | Practical guidance for the management of side effects during rucaparib therapy in a multidisciplinary UK setting | Therapeutic Advances in Medical Oncology | 2020 | 8 |
| 27 | Heterotopic abdominal pregnancy with persistent trophoblastic tissue | Acta Obstetricia Et Gynecologica Scandinavica | 2011 | 7 |
| 28 | An unusual gum lesion with a positive pregnancy test | BMJ: British Medical Journal | 2011 | 5 |
| 29 | A case of pregnancy following a modified Strassman procedure applied to treat a placental site trophoblastic tumour | BJOG: an International Journal of Obstetrics and Gynaecology | 2012 | 5 |
| 30 | Meigs syndrome presenting with axillary vein thrombosis and lymphadenopathy: a case report | Journal of Medical Case Reports | 2013 | 5 |
| 31 | Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer | Oncotarget | 2016 | 5 |
| 32 | Breast Cancer in the Setting of HIV | Pathology Research International | 2011 | 5 |
| 33 | PREDICT‐GTN 1: Can we improve the FIGO scoring system in gestational trophoblastic neoplasia? | International Journal of Cancer | 2023 | 4 |
| 34 | The HVTN 503/Phambili study: efficacy is always the issue | Lancet Infectious Diseases, The | 2011 | 3 |
| 35 | Positioning pemetrexed in the treatment of ovarian cancer | European Journal of Cancer | 2009 | 2 |
| 36 | Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer | European Journal of Cancer | 2010 | 2 |
| 37 | Glomerular filtration rate estimation for carboplatin dosing in patients with gynaecological cancers | ESMO Open | 2022 | 2 |
| 38 | Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy | International Journal of Gynecological Cancer | 2023 | 2 |
| 39 | Poor reception? | Lancet, The | 2009 | 1 |
| 40 | Prior exposure to chemotherapy: a marker of sensitivity and selection for antiangiogenic therapy in breast cancer? | Expert Review of Anticancer Therapy | 2014 | 1 |
| 41 | Recurrence of primitive germ cell tumour 20 years on | BMJ Case Reports | 2023 | 1 |
| 42 | Receptor-based predictors of response in breast cancer | Future Oncology | 2009 | 0 |
| 43 | Signet Ring Cell Carcinoma of the Bladder and Urachus | British Journal of Medical and Surgical Urology | 2011 | 0 |
| 44 | Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘ | British Journal of Cancer | 2013 | 0 |
